Similarly, another study indicated that the combination of MK-0752 (gamma secretase inhibitors) and Tocilizumab (IL6R antagonist) remarkably decreases the proportion of BCSCs and inhibits cell proliferation or tumor growth in BC, through Notch3 signaling pathway (Wang D. et al., 2018). This evidence concerns the gene NOTCH3 and breast cancer.